Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2003
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037346A1 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
05/08/2003US20030087952 17-Beta-hydroxysteroid dehydrogenase-II inhibitors
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087949 For treating neurodegenerative diseases, diseases of circulatory organs, hepatitis, renal diseases, inflammatory skin disorders, radiation disorders, viral diseases, prion diseases, etc.; preservatives
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087939 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087920 Butyne diol derivatives
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087909 Having an attached non-aromatic heterocyclic ring
05/08/2003US20030087908 Substituted triazinyl amide derivatives and methods of use
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders.
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087881 Quinazoline derivatives used to treat cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465382A1 Indole compound and medicinal use thereof
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307444A2 Substituted heterocyclic amides
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1415614A Technique for synthesizing Irbesartan
05/07/2003CN1107673C Pesticidal 1-aryl-3-iminopyrazoles
05/07/2003CN1107671C Imide derivatives
05/06/2003US6559307 Process for the preparation of substituted pyrimidines
05/06/2003US6559173 organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
05/06/2003US6559164 Substituted pyrroles suitable for continuous infusion
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/06/2003US6558435 Reactive crystallization method to improve particle size
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305297A1 Benzotriazoles containing alpha-cumyl groups substituted by heteroatoms and compositions stabilized therewith
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1305026A2 Barbituric acid analogs as therapeutic agents
05/02/2003EP1185516B1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/02/2003EP1105388B1 N-substituted azabicycloheptane derivatives, production and use thereof
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP1028950B1 7-substituted quinazolin-2,4-diones useful as antibacterial agents
05/02/2003EP1001813B1 Pharmaceutical formulations containing voriconazole
05/02/2003EP0988035B1 Caspases and apoptosis
05/02/2003EP0910563B1 Integrin receptor antagonists
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035060A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003035039A1 Methods of treatment using a gastric retained losartan dosage
05/01/2003WO2003035009A2 Treatment of acute myeloid leukemia with indolinone compounds
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
1 ... 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 ... 626